Aquilonius Sm

797 total citations
20 papers, 622 citations indexed

About

Aquilonius Sm is a scholar working on Neurology, Cellular and Molecular Neuroscience and Clinical Biochemistry. According to data from OpenAlex, Aquilonius Sm has authored 20 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Clinical Biochemistry. Recurrent topics in Aquilonius Sm's work include Neurological disorders and treatments (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Aquilonius Sm is often cited by papers focused on Neurological disorders and treatments (6 papers), Neuroscience and Neuropharmacology Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Aquilonius Sm collaborates with scholars based in Sweden. Aquilonius Sm's co-authors include Bengt Långström, Per Hartvig, Joakim Tedroff, Gunilla Jacobsson, Håkan Askmark, Hans Naver, Marie Pedersen, Arvid Carlsson, L. Svennerholm and L. Oreland and has published in prestigious journals such as Neurology, Experimental Neurology and Journal of the Neurological Sciences.

In The Last Decade

Aquilonius Sm

19 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aquilonius Sm Sweden 9 301 265 147 101 69 20 622
Youdim Mb Israel 14 190 0.6× 176 0.7× 114 0.8× 90 0.9× 61 0.9× 32 499
Aygul Balcioglu United States 11 182 0.6× 283 1.1× 124 0.8× 120 1.2× 74 1.1× 17 622
Victor Garza United States 16 104 0.3× 285 1.1× 251 1.7× 62 0.6× 75 1.1× 20 602
Hubert Flores United States 15 315 1.0× 188 0.7× 163 1.1× 122 1.2× 42 0.6× 28 723
Sakiko Nishibayashi Japan 14 107 0.4× 202 0.8× 182 1.2× 88 0.9× 68 1.0× 21 536
Dietlind Sorger Germany 17 164 0.5× 268 1.0× 340 2.3× 136 1.3× 108 1.6× 42 927
Jean-Christophe Delumeau France 14 346 1.1× 285 1.1× 307 2.1× 94 0.9× 71 1.0× 20 800
Helmut A. Ensinger Germany 13 89 0.3× 255 1.0× 337 2.3× 60 0.6× 82 1.2× 21 641
Teiko Kimpara Japan 12 235 0.8× 106 0.4× 370 2.5× 102 1.0× 60 0.9× 16 683
Masuhiro Ikeda Japan 14 167 0.6× 422 1.6× 422 2.9× 196 1.9× 32 0.5× 24 931

Countries citing papers authored by Aquilonius Sm

Since Specialization
Citations

This map shows the geographic impact of Aquilonius Sm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aquilonius Sm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aquilonius Sm more than expected).

Fields of papers citing papers by Aquilonius Sm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aquilonius Sm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aquilonius Sm. The network helps show where Aquilonius Sm may publish in the future.

Co-authorship network of co-authors of Aquilonius Sm

This figure shows the co-authorship network connecting the top 25 collaborators of Aquilonius Sm. A scholar is included among the top collaborators of Aquilonius Sm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aquilonius Sm. Aquilonius Sm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zetterberg, Lena, et al.. (2004). Objective assessment in cervical dystonia.. 1 indexed citations
2.
Gomes–Trolin, Cecilia, Ingela Nygren, Aquilonius Sm, & Håkan Askmark. (2002). Increased Red Blood Cell Polyamines in ALS and Parkinson's Disease. Experimental Neurology. 177(2). 515–520. 58 indexed citations
3.
Grundström, Eva, et al.. (2001). High 3H-vesamicol binding in ALS motor neurons - autoradiographic visualization of hyperactivity?. Acta Neurologica Scandinavica. 103(1). 2–6. 1 indexed citations
4.
Naver, Hans & Aquilonius Sm. (1997). 2-03-02 Treatment of focal hyperhidrosis with botulinum toxin. Journal of the Neurological Sciences. 150. S70–S71. 41 indexed citations
5.
Tedroff, Joakim, Marie Pedersen, Aquilonius Sm, et al.. (1996). Levodopa‐induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Neurology. 46(5). 1430–1430. 122 indexed citations
6.
Tedroff, Joakim, et al.. (1996). Functional positron emission tomographic studies of striatal dopaminergic activity. Changes induced by drugs and nigrostriatal degeneration.. PubMed. 69. 443–8. 5 indexed citations
7.
Tedroff, Joakim, Michala Pedersen, Aquilonius Sm, et al.. (1996). Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease measured by (11C)raclopride displacement and PET. 46. 1430. 28 indexed citations
8.
Lennernäs, Hans, Dag Nilsson, Aquilonius Sm, et al.. (1993). The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.. British Journal of Clinical Pharmacology. 35(3). 243–250. 94 indexed citations
9.
Sm, Aquilonius. (1991). What has PET told us about Parkinson's disease?. Acta Neurologica Scandinavica. 84(S136). 37–39. 4 indexed citations
10.
Hartvig, Per, Aquilonius Sm, Joakim Tedroff, et al.. (1991). Positron emission tomography of L-dopa utilization in the brains of rhesus monkeys and human volunteers.. PubMed. 376. 149–50. 7 indexed citations
11.
Bergström, K, Aquilonius Sm, Mats Bergström, et al.. (1989). [PET--new ways inside the body].. PubMed. 86(25). 2371–7.
12.
Hägglund, J., Aquilonius Sm, SA Eckernas, et al.. (1987). Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using11C-N-methyl-spiperone. Acta Neurologica Scandinavica. 75(2). 87–94. 86 indexed citations
13.
Hägglund, J., Aquilonius Sm, K Bergström, et al.. (1987). Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.. PubMed. 45. 99–101. 9 indexed citations
14.
Gillberg, Per‐Göran, S. S. Jossan, Håkan Askmark, & Aquilonius Sm. (1986). Large-section cryomicrotomy for in vitro receptor autoradiography. Journal of Pharmacological Methods. 15(2). 169–180. 30 indexed citations
15.
Carlsson, Arvid, Rolf Adolfsson, Aquilonius Sm, et al.. (1980). Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.. PubMed. 23. 295–304. 120 indexed citations
16.
Sm, Aquilonius & Pål Hartvig. (1980). [Survey of the prescription of anti-parkinson drugs in Sweden during the seventies].. PubMed. 77(30-31). 2594–5. 3 indexed citations
17.
Mäepea, Olav, et al.. (1979). Choline acetyltransferase activity in human blood and its diurnal oscillation--an artifact?. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 57(1). 36–8. 2 indexed citations
18.
Sm, Aquilonius. (1979). [Some neurophysiological viewpoints on states of confusion].. PubMed. 76(17). 1612–3. 2 indexed citations
19.
Sm, Aquilonius, J. Schüberth, & A. Sundwall. (1970). Studies on choline in cerebrospinal fluid.. PubMed. 28(1). 35–35. 3 indexed citations
20.
Sm, Aquilonius, et al.. (1970). Some effects of a choline acetyltransferase inhibitor.. PubMed. 28(1). 34–34. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026